Qilu Pharmaceutical Co., Ltd.

This study tests a new drug called QLG1218 (daprodustat) to see if it works as well as the current standard treatment for anemia in people on kidney dialysis. About 100 Chinese adults on dialysis will switch from their current anemia shot to either the new pill or continue a simi…

This study tests two experimental drugs (QLC5508 and QLH12016) alone or with standard hormone therapies in 212 men with advanced prostate cancer that has spread. The goal is to find safe doses and see if the combinations shrink tumors or lower PSA levels. Participants must have m…

This early-phase study tests a new drug called QLS5316 in about 300 adults with advanced solid tumors (including colorectal, stomach, head and neck, and lung cancers) that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the best…

This early-stage trial tests a new drug called QLS1410 in 78 healthy adults and people with mild high blood pressure. The main goal is to check safety and how the drug moves through the body. It is a first step to see if the drug might help control blood pressure in the future.

This study tests a new drug combination (QLC5513 plus QL1706, with or without platinum chemo) in people with advanced solid tumors that have spread. The goal is to find the safest dose and see if the treatment shrinks tumors. About 290 participants will join this early-phase tria…

This study tests an investigational drug called QLC7401 for people with high cholesterol that remains high despite taking standard cholesterol-lowering medications. About 780 adults will receive either the study drug or a placebo as a shot under the skin. The goal is to see if QL…

This study tests a new injection called QL2106 against the approved drug Tremfya for people with moderate to severe plaque psoriasis. About 318 adults will be randomly assigned to receive either QL2106 or Tremfya, and researchers will compare how well each clears skin symptoms af…

This study tests a new medicine called QLC7401 in adults with high cholesterol or mixed dyslipidemia who are not on other treatments. Participants receive injections of either the drug or a placebo to see if it safely lowers bad cholesterol. The goal is to manage cholesterol leve…

This study tests a new tablet called QLS1410 for people with primary aldosteronism, a condition where a hormone imbalance causes high blood pressure. About 60 adults will receive either the drug or a placebo daily for up to 12 weeks. The goal is to see if the drug safely lowers b…

This study tests whether a biosimilar called QL2107 works the same as the drug Keytruda (pembrolizumab) when given after surgery for non-small cell lung cancer. About 122 adults with stage II or IIIA lung cancer who have already had surgery and chemotherapy will receive either QL…

This study tests a new tablet called QLC1401 combined with standard cancer drugs (CDK4/6 or mTOR inhibitors) in people with ER+/HER2- advanced or metastatic breast cancer. The goal is to find a safe dose and see if the combination shrinks tumors. About 96 participants will join t…

This study tests an experimental capsule called QLS12010 in 180 adults with moderate-to-severe rheumatoid arthritis. Participants will receive either one of three doses of the drug or a placebo for 12 weeks. The goal is to see if the drug reduces disease activity and joint swelli…

This study tests a new medicine called QL0911 in children aged 1 to 17 with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. The trial compares QL0911 to a placebo to see if it safely raises platelet counts to s…

This study compares a new drug, QLG1091, to an approved drug, Rybelsus, in adults with type 2 diabetes who are already taking metformin. About 478 participants will take either QLG1091 or Rybelsus for 26 weeks to see if the new drug works as well at lowering blood sugar. The goal…

This study tests an experimental drug called GM1 in 276 people with Parkinson's disease who have motor fluctuations—times when their medication wears off and movement becomes difficult. Participants receive either GM1 or a placebo injection over 85 days while continuing their usu…

This study tests a new capsule called QLS12010 in 102 adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. The trial has two parts: first, an open-label phase to see if the drug works and is safe; second, a placebo-controlled phase to find the b…

This early-stage study tests a new drug called QLS5308 in about 192 adults with advanced solid tumors that cannot be removed by surgery or radiation. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. The study has two parts: first…

This study tests a new drug called QL1207H against an approved treatment (Eylea) for wet age-related macular degeneration, a leading cause of vision loss. About 356 adults aged 50 and older with active disease will receive injections every 4 weeks for 3 doses, then every 16 weeks…

This study tests a new drug (QLS31905) combined with chemotherapy, with or without another drug (QLQ2107), in 120 people with advanced bile duct cancer that has a specific marker (CLDN18.2). The goal is to see if the combination shrinks tumors or slows the disease. Participants m…

This study tests a new drug called QLS5132 given with other cancer treatments for people with advanced solid tumors, including stomach, lung, endometrial, and ovarian cancers. The goal is to find safe doses and see if the combination can shrink tumors. About 626 participants will…

This study tests whether adding romiplostim N01 to standard treatment helps people with severe aplastic anemia, a condition where the bone marrow fails to make enough blood cells. About 210 participants will receive either the drug or a placebo alongside standard therapy. The mai…

This study tests if a new drug called QL2302 works as well and is as safe as the current drug Tezspire for adults with severe asthma that is not controlled by standard treatments. About 636 adults aged 18-80 will get either QL2302 or Tezspire as an injection every 4 weeks for 48 …

This early-phase study tests a new drug called QLS5212 in 100 people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the body a…

This study tests an investigational drug called QLC7401 in adults with heterozygous familial hypercholesterolemia, an inherited condition causing very high cholesterol. About 120 participants already on cholesterol-lowering medication will receive either QLC7401 or a placebo as a…

This early-stage trial tests a new drug called QLS2313 in 124 adults with blood cancers (like lymphoma or leukemia) that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors…

This study tests a new drug called QLS4131, given as a shot under the skin, combined with other medicines for people with malignant plasma cell neoplasms, a group of blood cancers including multiple myeloma. The goal is to see if these combinations are safe and help shrink or con…

This study tests an experimental capsule called QLS12010 in 160 adults with moderate-to-severe atopic dermatitis (eczema). Half will get the drug, half a placebo, and researchers will check if it reduces eczema severity and itching over 16 weeks. The goal is to see if the drug is…

This early-stage study tests a single injection of a new drug called QLH2405 in 68 healthy volunteers and people with mild memory problems or mild Alzheimer's disease. The main goal is to check if the drug is safe and how the body processes it. This is a first step to see if the …

This early-stage study looks at how food changes the way a new drug, QLS1410, is absorbed in the body. It involves 12 healthy Chinese adults who will take the drug once with food and once without. The goal is to gather information, not to treat high blood pressure.

This early-stage study tests whether a new drug, QLS7305, is safe in 60 healthy adults in China. Participants receive either the drug or a placebo, and are closely monitored for side effects, how the drug moves through the body, and its effect on the immune system's complement sy…

This early-stage study tests QL2401, a potential treatment for a liver condition called MASH, in 70 healthy Chinese adults. Participants receive either the drug or a placebo to check for side effects and how the body processes it. The goal is safety and dosing information, not tr…

This early-stage study tests whether a new drug called QL2109 works like the approved cancer drug Darzalex in healthy Chinese men. The goal is to compare how the body processes each drug and check for side effects. No treatment for multiple myeloma is given — this is a safety and…

This early-stage study tests a new drug called QL2302 in 178 healthy adults aged 18 to 45. It compares how the body processes QL2302 versus the approved drug Tezspire, and checks for side effects and immune responses after a single dose. The goal is to see if QL2302 works similar…